Nova Eye Medical Launches New Generation Canaloplasty Device for Glaucoma

Nova Eye Medical announced the launch of its next generation canaloplasty device, iTrack Advance, in select markets in Europe and the Asia Pacific.  

The iTrack Advance features the proprietary illuminated fiber optic tip of the original iTrack device, which allows the surgeon to continuously monitor the location of the device in Schlemm’s canal. It also features a proprietary guide-wire mechanism that enables the microcatheter to catheterize up to 360 degrees of the canal in a single intubation. 

The new iTrack Advance device is designed to improve the overall efficiency of the canaloplasty procedure. The company expects the introduction of iTrack Advance to drive increased surgeon uptake of the canaloplasty procedure by cataract surgeons and comprehensive ophthalmologists. To date, the original iTrack device has been used almost exclusively by glaucoma surgeons.

“Canaloplasty is globally recognized as a highly effective treatment option for glaucoma. The intricacies of the procedure, however, which have included manual intubation of the microcatheter through the canal using forceps, previously limited its adoption by a broad cross section of surgeons," Tom Spurling, Managing Director of Nova Eye Medical, said in a company news release. 

“With iTrack Advance, we have taken the clinically proven iTrack microcatheter and engineered it into an intuitive, easy-to-use handpiece. It’s the perfect marriage of clinical excellence and surgical efficiency.”

“We see iTrack Advance being readily adopted into the glaucoma toolkit of cataract surgeons and comprehensive ophthalmologists. This will ensure improved access to the canaloplasty procedure for a greater number of glaucoma patients worldwide,” added Mr. Spurling.

Over the coming months, the company will roll-out the new iTrack Advance in Europe via a series of market development and clinical development initiatives, including a surgical training program in Germany.                 

The company will showcase the iTrack Advance (not for sale or use in the USA) to surgeons from outside the USA during the 2022 annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS), April 22-26 in Washington DC.

The iTrack Advance builds on the legacy of the company’s proprietary iTrack device. Launched in 2008, the iTrack has been used in more than 100,000 canaloplasty procedures globally.